Bente Magny Bergersen

     

    Author network for Bente Magny Bergersen by COREMINE medical


    Publications 2011

    Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
    Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
    BMC Infect Dis, 11, 75
    DOI 10.1186/1471-2334-11-75, PubMed 21435254

    Publications 2009

    Skeie L, Bugge H, Negaard A, Bergersen BM (2009)
    Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study
    HIV Med, 11 (3), 170-7
    DOI 10.1111/j.1468-1293.2009.00761.x, PubMed 19780861

    Publications 2006

    Bergersen BM (2006)
    Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy
    Drugs, 66 (15), 1971-87
    DOI 10.2165/00003495-200666150-00006, PubMed 17100407

    Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
    Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
    Scand J Infect Dis, 38 (8), 682-9
    DOI 10.1080/00365540500361302, PubMed 16857615

    Publications 2005

    Bergersen BM, Sandvik L, Ellingsen I, Bruun JN (2005)
    Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive
    HIV Med, 6 (4), 260-7
    DOI 10.1111/j.1468-1293.2005.00305.x, PubMed 16011531

    Bergersen BM, Tonstad S, Sandvik L, Bruun JN (2005)
    Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipients
    Int J STD AIDS, 16 (5), 365-9
    DOI 10.1258/0956462053888808, PubMed 15949067

    Publications 2004

    Bergersen BM, Sandvik L, Bruun JN (2004)
    Body composition changes in 308 Norwegian HIV-positive patients
    Scand J Infect Dis, 36 (3), 186-91
    DOI 10.1080/00365540410019273, PubMed 15119363

    Bergersen BM, Sandvik L, Bruun JN, Tonstad S (2004)
    Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects
    Eur J Clin Microbiol Infect Dis, 23 (8), 625-30
    DOI 10.1007/s10096-004-1177-6, PubMed 15322938

    Publications 2003

    Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN (2003)
    Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients
    Eur J Clin Microbiol Infect Dis, 22 (12), 731-6
    DOI 10.1007/s10096-003-1034-z, PubMed 14610658

    Page visits: 1805